Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Global Diagnostics Australia Incorporates Artificial Intelligence Into Its Radiology Applications

Partnering with Aidoc to identify and prioritize patients with time-sensitive medical conditions


News provided by

Aidoc , Global Diagnostics Australia

08 Aug, 2019, 04:00 IDT

Share this article

Share toX

Share this article

Share toX

PERTH, Australia, Aug. 8, 2019 /PRNewswire/ -- Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), announced today that it has adopted artificial intelligence (AI) applications into its radiology workflow, and is one of the first diagnostic imaging companies in Australia to do so. GDA has partnered with leading international AI company, Aidoc, to incorporate their algorithms into GDA's care management pathway. These AI applications will expedite patient diagnosis and treatment for several head, neck and chest conditions.

Global Diagnostics logo
Global Diagnostics logo
Integral Diagnostics logo
Integral Diagnostics logo
Aidoc logo
Aidoc logo

Aidoc's "Always-on" AI solution analyzes medical images and prioritizes the patient list  to ensure that the most critical are diagnosed and treated first. The introduction of AI by GDA marks a milestone for Aidoc as it expands into Australia.

Aidoc has recently received Therapeutic Goods of Australia (TGA) clearance, and already has Food and Drug Administration (FDA - USA) approvals and European Union CE markings on AI applications for three important medical conditions: Intracranial Hemorrhage, Pulmonary Embolism, and Cervical-Spine Fracture.

As well as onsite hospital radiology services, GDA also provides tele-radiology services to remote and rural parts of Western Australia. Using AI to flag critical findings for these patients helps expediate their care when time is critical, or when they need to be transferred to larger facilities in the metropolitan area for urgent treatment.

"The increase in demand for radiology services in regional areas has created an increased workload for radiologists servicing the regions. AI is being used to effectively triage the truly urgent cases, and this allows the radiologist to appropriately prioritize patients in most need of care. The application provides additional peace of mind for radiologists, patients and for referring doctors, that urgent life-threatening conditions are found and treated faster. AI has arrived and it is here to stay, it is going to materially improve patient care and service well into the future," stated Dr. Nazar Bokani, Clinical Director, GDA.

"We're honoured to work with Integral Diagnostics and GDA to bring positive clinical impact on patient care. Aidoc's partnership with IDX and GDA marks a true turning point. Together we are providing the advancements of artificial intelligence to over four hundred thousand patients across Western Australia, ensuring access to the highest level of treatment in even the most remote areas," said Elad Walach, Aidoc CEO.

For more information, please contact:

Paul McCrow

General Manager

Global Diagnostics Australia

Email: [email protected]

www.globaldiagnostics.com.au

Ariella Shoham 

Vice President Marketing 

Aidoc

Email: [email protected] 

www.aidoc.com

SOURCE Aidoc; Global Diagnostics Australia

Related Links

https://www.aidoc.com/

Modal title

Also from this source

New Clinical Outcomes at ISC 2026 Demonstrate Aidoc's Superior AI-Powered Triage of Large and Medium Vessel Occlusions

New Clinical Outcomes at ISC 2026 Demonstrate Aidoc's Superior AI-Powered Triage of Large and Medium Vessel Occlusions

Aidoc, the leading clinical AI platform, today announced the presentation of two new scientific abstracts comparing AI-powered stroke solutions at...

Aidoc Secures FDA Clearance for Healthcare's First Comprehensive Foundation Model AI

Aidoc Secures FDA Clearance for Healthcare's First Comprehensive Foundation Model AI

Aidoc, the pioneer and global leader of clinical AI, today announced that the U.S. Food and Drug Administration (FDA) has cleared the healthcare...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Joint Ventures

Joint Ventures

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.